Banevicius, M., Gedvilaite, G., Vilkeviciute, A., et al., Association of relative leukocyte telomere length and genetic variants in telomere-related genes (TERT, TERT-CLPTM1, TRF1, TNKS2, TRF2) with atrophic age-related macular degeneration, Ophthalmol. Genet., 2021, vol. 42, no. 2, pp. 189–194. https://doi.org/10.1080/13816810.2021.1881976

CAS  Article  Google Scholar 

Berezutsky, M.A., Durnova, N.A., and Vlasova, I.A., Experimental and clinical studies of mechanisms of the antiaging effects of chemical compounds in Astragalus membranaceus, Adv. Gerontol., 2020, vol. 10, no. 2, pp. 142–149. https://doi.org/10.1134/S2079057020020046

Article  Google Scholar 

Bernadotte, A., Mikhelson, V.M., and Spivak, I.M., Markers of cellular senescence. Telomere shortening as a marker of cellular senescence, Aging (Albany, New York), 2016. https://doi.org/10.18632/aging.100871

Bhisitkul, R., Mendes, T., Rofagha, S., et al., Macular atrophy progression and 7-year vision outcomes in subjects from the ANCHOR, MARINA, and HORIZON studies: the SEVEN-UP study, Amer. J. Ophthalmol., 2015, vol. 159, no. 5, pp. 915–924. https://doi.org/10.1016/j.ajo.2015.01.032

Article  Google Scholar 

Cawthon, R.M., Telomere measurement by quantitative PCR, Nucleic Acids Res., 2002, vol. 30, no. 10. e47. https://doi.org/10.1093/nar/30.10.e47

Coscas, F., Cabral, D., Pereira, T., et al., Quantitative optical coherence tomography angiography biomarkers for neovascular age-related macular degeneration in remission, PLoS One, 2018, vol. 13, no. 10. e0205513.

De Punder, K., Heim, C., Wadhwa, P.D., and Entringer, S., Stress and immunosenescence: the role of telomerase, Psychoneuroendocrinology, 2019, vol. 101, pp. 87–100. https://doi.org/10.1016/j.psyneuen.2018.10.019

CAS  Article  Google Scholar 

Demanelis, K., Jasmine, F., Chen, L.S., et al., Determinants of telomere length across human tissues, Science, 2020, vol. 369, no. 6509. eaaz6876. https://doi.org/10.1126/science.aaz6876

Dow, C.T. and Harley, C.B., Evaluation of an oral telomerase activator for early age-related macular degeneration—a pilot study, Clin. Ophthalmol., 2016, vol. 10, pp. 243–249. https://doi.org/10.2147/OPTH.S100042

CAS  Article  Google Scholar 

Ebner, C., Wernigg, C., Schütze, C., et al., Retinal pigment epithelial characteristics in eyes with neovascular age-related macular degeneration, Wien Klin. Wochenschr., 2021, vol. 133, pp. 123–130. https://doi.org/10.1007/s00508-020-01718-6

CAS  Article  Google Scholar 

Fayzieva, U.S., Maksudova, Z.R., Siddikov, Z.U., et al., Oct-angiography in the efficiency assessment of the anti-angiogenic therapy of exudative form of age-related macular degeneration, Modern Technol. Ophthalmol., 2019, vol. 1, pp. 305–309. https://doi.org/10.25276/2312-4911-2019-1-305-309

Article  Google Scholar 

Framme, C., Eter, N., Hamacher, T., et al., Aflibercept for patients with neovascular age-related macular degeneration in routine clinical practice in Germany: twelve-month outcomes of PERSEUS, Ophthalmol. Retina, 2018, vol. 2, no. 6, pp. 539–549. https://doi.org/10.1016/j.oret.2017.09.017

Article  Google Scholar 

Fursova, A.Z., Derbeneva, A.S., Vasilyeva, M.A., et al., Different types localisation of retinal fluid as prognostic biomarkers in the choice of anti-VEGF therapy for age-related macular degeneration, Vestn. Oftalmol., 2020, vol. 136, no. 2, pp. 227–234. https://doi.org/10.17116/oftalma2020136062227

Article  Google Scholar 

Fursova, A.Z., Zabanova, V.E., Gamza, Y.A., et al., Ophthalmic safety profile of antiangiogenic therapy, Vestn. Oftalmol., 2021, vol. 137, no. 2, pp. 114–122. https://doi.org/10.17116/oftalma2021137021114

Article  Google Scholar 

Holz, F.G., Tadayoni, R., Beatty, S., et al., Multi-country real-life experience of anti-vascular endothelial growth factor therapy for wet age-related macular degeneration, Brit. J. Ophthalmol., 2015, vol. 99, pp. 220–226. https://doi.org/10.1136/bjophthalmol-2014-305327

Article  Google Scholar 

Immonen, I., Seitsonen, S., Saionmaa, O., and Fyhrquist, F., Leucocyte telomere length in age-related macular degeneration, Acta Ophthalmol., 2013, vol. 91, no. 5, pp. 453–456. https://doi.org/10.1111/j.1755-3768.2012.02427.x

CAS  Article  Google Scholar 

Lambert, N.G., ElShelmani, H., Singh, M.K., et al., Risk factors and biomarkers of age-related macular degeneration, Progr. Retinal Eye Res., 2016, vol. 54, pp. 64–102. https://doi.org/10.1016/j.preteyeres.2016.04.003

CAS  Article  Google Scholar 

Maximov, V.N., Malyutina, S.K., Orlov, P.S., et al., Leukocyte telomere length as an aging marker and risk factor for human age-related diseases, Adv. Gerontol., 2017, vol. 7, pp. 101–106. https://doi.org/10.1134/S2079057017020102

Article  Google Scholar 

Neroev, V.V., Astakhov, Y.S., Korotkih, S.A., et al., Protocol of intravitreal drug delivery. Consensus of the Expert Council of retina and optic nerve diseases of the All-Russian Public Organization “Association of Ophthalmologists,” Vestn. Oftalmol., 2020, vol. 136, pp. 251–263. https://doi.org/10.17116/oftalma2020136062251

CAS  Article  Google Scholar 

Peden, M., Suñer, I., Hammer, M., and Grizzard, W., Long-term outcomes in eyes receiving fixed-interval dosing of anti-vascular endothelial growth factor agents for wet age-related macular degeneration, Ophthalmology, 2015, vol. 122, no. 4, pp. 803–808. https://doi.org/10.1016/j.ophtha.2014.11.018

Article  Google Scholar 

Stefler, D., Malyutina, S., Maximov, V., et al., Leukocyte telomere length and risk of coronary heart disease and stroke mortality: prospective evidence from a Russian cohort, Sci. Rep., 2018, vol. 8, p. 16627. https://doi.org/10.1038/s41598-018-35122-y

Article  Google Scholar 

Telegina, D.V., Kozhevnikova, O.S., and Kolosova, N.G., Molecular mechanisms of cell death in retina during development of age-related macular degeneration, Adv. Gerontol., 2017, vol. 7, pp. 17–24. https://doi.org/10.1134/S2079057017010155

Article  Google Scholar 

Waldstein, S.M., Simander, C., Staurenghi, G., et al., Morphology and visual acuity in aflibercept and ranibizumab therapy for neovascular age-related macular degeneration in the view trials, Ophthalmology, 2016, vol. 123, pp. 1521–1529. https://doi.org/10.1016/j.ophtha.2016.03.037

Article  Google Scholar 

Wang, J., Feng, Y., Han, P., et al., Photosensitization of A2E triggers telomere dysfunction and accelerates retinal pigment epithelium senescence, Cell Death Dis., 2018, vol. 9, no. 2, p. 178. https://doi.org/10.1038/s41419-017-0200-7

CAS  Article  Google Scholar 

Weng, X., Zhang, H., Kan, M., et al., Leukocyte telomere length is associated with advanced age-related macular degeneration in the Han Chinese population, Exp. Gerontol., 2015, no. 69, pp. 36–40. https://doi.org/10.1016/j.exger.2015.06.004

Wong, W., Su, X., Li, X., et al., Global prevalence of age-related macular degeneration and disease burden projection for 2020 and 2040: a systematic review and meta-analysis, Lancet Global Health, 2014, vol. 2, no. 2, рр. e106–е116. https://doi.org/10.1016/S2214-109X(13)70145-1

Wykoff, C.C., Clark, W.L., Nielsen, J.S., et al., Optimizing anti-VEGF treatment outcomes for patients with neovascular age-related macular degeneration, J. Manage. Care Spec. Pharm., 2018, vol. 24, pp. 3–15. https://doi.org/10.18553/jmcp.2018.24.2-a.s3

Article  Google Scholar